The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Open accessAbstract
The inherited deficiency of adenosine deaminase (adenosine aminohydrolase; EC 3.5.4.4) activity in humans is associated with an immunodeficiency. Some of the immunodeficient and enzyme-deficient patients respond immunologically to periodic infusions of irradiated erythrocytes containing adenosine deaminase. It has been previously reported that erythrocytes and lymphocytes from immunodeficient ane enzyme-deficient children contained increased concentrations of ATP, and in the one child studied after erythrocyte infusion therapy, the intracellular level of ATP diminished. Using high-pressure liquid chromatography that resolves ATP and 2'-dATP, we have observed greater than 50-fold elevations of dATP in the erythrocytes of immunodeficient, adenosine deaminase-deficient patients but not in the erythrocytes of an immunocompetent adenosine deaminase-deficient patient. The erythrocyte dATP in two unrelated adenosine deaminase-deficient, immunodeficient patients disappeared after infusion of normal erythrocytes. We propose that deoxyadenosine, a substrate of adenosine deaminase, is the potentially toxic substrate in adenosine deaminase deficiency, and that the mediator of the toxic effect is dATP, a recognized potent inhibitor of ribonucleotide reductase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
Giblett, E., Anderson, J., Cohen, F., Pollara, B., & Meuwissen, H. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92345-8 · Cited by 1,636
Carson, D. A., Kaye, J., & Seegmiller, J. E. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5677 · Cited by 414
Green, H., & Chan, T. (1973) · Science · doi:10.1126/science.182.4114.836 · Cited by 268
Wolberg, G., Zimmerman, T. P., Hiemstra, K., Winston, M., & Chu, L.-C. (1975) · Science · doi:10.1126/science.167434 · Cited by 266
Enzyme Replacement Therapy for Adenosine Deaminase Deficiency and Severe Combined Immunodeficiency
Polmar, S. H., Stern, R. C., Schwartz, A. L., Wetzler, E. M., Chase, P. A., & Hirschhorn, R. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612092952402 · Cited by 248
Self-citationSevere Combined Immunodeficiency and Adenosine Deaminase Deficiency
Parkman, R., Gelfand, E. W., Rosen, F. S., SANDERSON, A. R., & Hirschhorn, R. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504032921402 · Cited by 246
Self-citationAdenosine deaminase from human erythrocytes: Purification and effects of adenosine analogs
Agarwal, R. P., Sagar, S. M., & Parks, R. E. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90245-2 · Cited by 205
Deoxyribonucleotide Pools and Deoxyribonucleic Acid Synthesis in Cultured Mouse Embryo Cells
Nordenskjöld, B. A., Skoog, L., Brown, N. C., & Reichard, P. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62763-2 · Cited by 159
Effect of Cyclic 3',5'-Adenosine Monophosphate and Theophylline on Lymphocyte Transformation
Hirschhorn, R., Grossman, J., & Weissmann, G. (1970) · Experimental Biology and Medicine · doi:10.3181/00379727-133-34690 · Cited by 158
Self-citationPurine metabolism in adenosine deaminase deficiency.
Mills, G. C., Schmalstieg, F. C., Trimmer, K. B., Goldman, A. S., & Goldblum, R. M. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2867 · Cited by 157
Cited by
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,550
The Primary Immunodeficiencies
Rosen, F. S., Cooper, M. D., & Wedgwood, R. J. P. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408023110506 · Cited by 1,077
Purinergic Signalling: Pathophysiological Roles
Maria P., A., & Geoffrey, B. (1998) · Japanese Journal of Pharmacology · doi:10.1254/jjp.78.113 · Cited by 444
Metadata
- Authors
- Cohen, A., Hirschhorn, R., Horowitz, S. D., Rubinstein, A., Polmar, S. H., Hong, R., & Martin, D. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1978-01
- Volume
- 75
- Issue
- 1
- Pages
- 472-476
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079752228
- Cited by
- 399
- References
- 20
- FWCI
- 19.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. https://app.cochat.ai/papers/10.1073/pnas.75.1.472
- The paper
- Cohen, A., Hirschhorn, R., Horowitz, S. D., Rubinstein, A., Polmar, S. H., Hong, R., & Martin, D. W. (1978). Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.75.1.472
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.